A physician from the Leiden University Medical Center (LUMC) has spoken about the mental health effects of the diabetes drug Ozempic, covering both the positive and negative consequences, according to a report by quest.nl published on August 15, 2026.
The doctor’s comments, as summarized by quest.nl, address how the medication influences psychological well-being. While the full article text was not available, the headline indicates that the LUMC expert highlighted a dual impact: benefits as well as drawbacks for patients using the drug.
Ozempic, originally developed to treat type 2 diabetes, has gained widespread attention for its weight-loss effects. The drug works by mimicking a hormone that regulates appetite, which can lead to significant reductions in body weight. However, as its use has expanded, questions have emerged about how it affects patients beyond physical changes.
The LUMC doctor’s remarks suggest that mental health outcomes are not uniform. Some patients may experience improvements, potentially linked to weight loss and related lifestyle changes. Others may face negative psychological effects, which the physician reportedly detailed in the interview with quest.nl.
This discussion comes amid growing public interest in the drug’s broader impact. As more people use Ozempic for weight management, medical professionals are increasingly examining the full spectrum of its effects, both physical and mental.
The quest.nl report adds to a growing body of coverage on the drug’s side effects, which have been a topic of debate among healthcare providers and patients alike. The LUMC physician’s perspective offers a clinical view on a subject that is often discussed in popular media.
Watch for further research and clinical guidance on managing the psychological side effects of GLP-1 medications like Ozempic.
